首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Ipilimumab/nivolumabRenal granulomatous arteritis: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2020年
/ 1824卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-020-84136-4
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:168 / 168
相关论文
共 50 条
[21]
NivolumabRenal allograft rejection and renal failure: case report
Reactions Weekly,
2019,
1747
(1)
: 209
-
209
[22]
Ipilimumab/nivolumabBilateral granulomatous anterior uveitis, hypotony and nuclear cataracts : case report
Reactions Weekly,
2021,
1847
(1)
: 258
-
258
[23]
Ipilimumab/nivolumabGiant cell temporal arteritis followed by severe encephalopathy: case report
Reactions Weekly,
2025,
2045
(1)
: 202
-
202
[24]
IpilimumabAcute renal granulomatous arteritis leading to acute kidney injury: case report
Reactions Weekly,
2019,
1780
(1)
: 197
-
197
[25]
Granulomatous dermatitis associated with ipilimumab therapy (ipilimumab associated granulomatous dermatitis)
Kubicki, Shelby L.
论文数:
0
引用数:
0
h-index:
0
机构:
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
Kubicki, Shelby L.
Welborn, Macartney E.
论文数:
0
引用数:
0
h-index:
0
机构:
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
Welborn, Macartney E.
Garg, Naveen
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
Garg, Naveen
Aung, Phyu P.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
Aung, Phyu P.
Patel, Anisha B.
论文数:
0
引用数:
0
h-index:
0
机构:
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,FCT11-5000,Unit 1452, Houston, TX 77030 USA
UTHlth Houston, McGovern Med Sch, Dept Dermatol, Houston, TX USA
Patel, Anisha B.
JOURNAL OF CUTANEOUS PATHOLOGY,
2018,
45
(08)
: 636
-
638
[26]
Ipilimumab/nivolumabEsophageal eosinophilia, granulomatous uterine inflammation and immune-mediated arthritis: case report
Reactions Weekly,
2020,
1829
(1)
: 222
-
222
[27]
Ipilimumab/NivolumabPauci-immune necrotising and crescentic glomerulonephritis with granulomatous interstitial nephritis: case report
Reactions Weekly,
2024,
2036
(1)
: 234
-
234
[28]
Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly,
2022,
1887
(1)
: 396
-
396
[29]
Ipilimumab/pembrolizumabIleus: case report
Reactions Weekly,
2023,
1956
(1)
: 287
-
287
[30]
Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly,
2021,
1854
(1)
: 199
-
199
←
1
2
3
4
5
→